Merck’s $10.8bn Acquisition of Prometheus Biosciences
By Athean Myat, Coby Lai, Michelle Liu, Carden Olsson and Angelina Gart (Cornell University) Photo: Sangharsh Lohakare (Unsplash)...
Merck’s $10.8bn Acquisition of Prometheus Biosciences
BP’s $1.3bn Acquisition of TravelCenters of America
Xylem’s $7.5bn Acquisition of Evoqua
Clayton, Dubilier & Rice's $7bn Acquisition of Focus Financial Partners
Novozymes’ $12.3bn Acquisition of Chr. Hansen
L3Harris’ $4.7bn Acquisition of Aerojet Rocketdyne
NRG Energy’s $2.8bn Acquisition of Vivint Smart Home
Intercontinental Exchange’s $16bn Acquisition of Black Knight
Pfizer’s $5.4bn Acquisition of Global Blood Therapeutics
GSK’s Demerger of Haleon
Orange’s €18.6bn Merger with MásMóvil
Oracle’s $28bn Acquisition of Cerner Corporation
Todd Boehly’s £4.25bn Acquisition of Chelsea FC
RBC’s C$13.5bn Acquisition of HSBC Canada
Advent International’s $6.4bn Acquisition of Maxar Technologies
Thoma Bravo’s $8bn Acquisition of Coupa Software
Mobileye’s $17bn IPO
Estee Lauder’s $2.8bn Acquisition of Tom Ford
Broadcom’s $61bn Acquisition of VMware
Johnson & Johnson’s $16.6bn Acquisition of Abiomed